Lv1
56 积分 2023-12-22 加入
Engineering CD3/CD137 dual specificity into a DLL3-targeted T-cell engager enhances T-cell infiltration and efficacy against small cell lung cancer
4天前
已完结
New immune cell engagers for cancer immunotherapy
11天前
已完结
Monoclonal antibodies to human colorectal epithelium: Markers for differentiation and tumour characterization
30天前
已关闭
Antibody Half‐Life
3个月前
已完结
Antibody-Dependent Cellular Cytotoxicity (ADCC)
3个月前
已完结
Future unmet medical need as a guiding principle for pharmaceutical R&D
3个月前
已完结
Advances in antibody-based therapy in oncology
4个月前
已完结
Designing stable humanized antibodies
4个月前
已完结
Overcoming TGFβ-mediated immune evasion in cancer
4个月前
已完结
New immune cell engagers for cancer immunotherapy
4个月前
已完结
皖公网安备34019202002308
